Tryp (TRYP.C) has 4 Phase 2 psilocybin trials upcoming, but will they be able to afford it?
Phase 2 I’ve written previously about how expensive clinical trials are, and how not many companies are actually cashed enough to run the trials…
Read storyTaylor has been covering the cannabis and psychedelics space since 2017 and has been investing in the stock market for 13 years. He started his own stock market news site High Energy Trading which he grew to 130,000 users and eventually exited from. Before writing about stocks he covered music events like Shambhala Music Festival and Pemberton Music Festival, with publishings in several media outlets including VICE. In his off time, he enjoys making electronic music, playing basketball, guzzling mushroom supplements, taking photos of street dogs, and searching out Colombian coffee plantations to buy.
Phase 2 I’ve written previously about how expensive clinical trials are, and how not many companies are actually cashed enough to run the trials…
Common vs preferred shares A company can go bust for a number of reasons. It happens all the time. In those dire circumstances, the…
Cruel, cruel summer It’s near the end of September and the seasons are changing. Chet Hanks predicted this past summer would be a…
SPL026 Small Pharma (DMT.V), a psychedelics company focusing on DMT announced today it’s completed Phase 1 for its drug candidate SPL026, (a DMT derivative)…
One billion shares No matter what FSD Pharma (HUGE.N) does, I will always remember them as the company that bragged endlessly about having more…
The MSM Tim Ferriss, author of The 4 Hour Work Week, The 4 Hour Chef, The 4 Hour body etc. is ponying up $800,000…
Keeping up with the Joneses In 2018 a group of Vancouver lawyers penny stock enthusiasts joined up under The Bridge Mark group to provide…
Diverse clinics Ketamine One (MEDI.NE) announced it’s adding 2 more locations to its already bustling ketamine clinic network. Through an acquisition last week, Ketamine…
Mainstream adoption I was 19 rows back, dead center as Roger Waters played Comfortably Numb next to 80-foot Pink Floyd stage props. The MDMA…
Biting the hand that feeds you Nova Mentis Life Sciences (NOVA.C) director Steven Feldman has some interesting thoughts around vaccines, and as a life…
“My faith is with technology and with psychedelics. Politics aren’t going to take us much further. ” – Terence McKenna September 20th, 2021…
Episode 2 Earlier this year Mindmed (MNMD.Q) co-founder JR Rahn went on an epic selling spree, selling nearly 90% of his holdings without telling…